Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Reeves, Barney, Evans, Rebecca, Harding, Simon P. and Lotery, Andrew (2019) Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants. Investigative Ophthalmology & Visual Science, 60 (9), 1214.

Abstract

Purpose: To describe treatment frequency for neovascular age-related macular degeneration (nAMD), and visual acuity, in IVAN trial participants in the UK’s national health service during the 5 to 7 years since exiting the IVAN trial.
Methods: This extension studied participants who completed the IVAN clinical trial. Consent at enrolment allowed for collection of clinical data beyond trial exit but not for further research visits. A new ethics approval allowed surviving participants to be invited to attend a study visit, extraction of usual care visit data if they did not wish to attend and for deceased participants. We examined the medical records from trial exit (04/2010-11/2012) to end of follow-up (04/2016-06/2017) for usual care and research visits, extracting: visit date; distance visual acuity (DVA) for both study and fellow eyes; treatments for nAMD administered to either eye. We derived duration of study eye monitoring and …

This record has no associated files available for download.

Contributors

Author: Andrew Lotery

Download statistics